Literature DB >> 2668080

Determination of peritoneal glucose kinetics in rats: implications for the peritoneal implantation of closed-loop insulin delivery systems.

G Velho1, P Froguel, G Reach.   

Abstract

Peritoneal glucose kinetics were evaluated in the anaesthetized rat, to assess whether the peritoneal cavity would be a suitable site for the implantation of membrane-protected islets of Langerhans (bioartificial pancreas) or the glucose sensor of an artificial B cell. Glucose was measured in peritoneal fluid samples aspirated by needle puncture. Basal peritoneal and blood glucose concentrations were identical in 16 h fasted (n = 4) and non fasted (n = 3) animals. After 10 min of an i.v. glucose infusion (n = 15) the increment in peritoneal glucose concentration was 63 +/- 3% of the increment in blood glucose concentration and both values were significantly correlated (r = 0.92; p less than 0.001). After 10 min of glucose clamping (12.6 +/- 0.8 mmol/l), the increment in peritoneal glucose concentration was 69 +/- 3% (n = 5; p less than 0.05) of the increment in blood glucose concentration. In three additional experiments it was 93 +/- 3% of the increment in blood glucose concentration (NS), after 30 min of glucose clamping (8.0 +/- 0.5 mmol/l). Peritoneal glucose concentration monitored by a glucose sensor: (a) followed blood glucose sluggishly during a glucose clamp (n = 5), confirming the data shown above, (b) followed blood glucose with a 5 min delay and reached the same plateau after the intravenous injection of 1U insulin (n = 3; NS). We conclude that peritoneal glucose reflects blood glucose at basal state and during variations of glycaemia, nevertheless, presenting heterogeneous kinetics. These kinetics might be appropriate for a bioartificial pancreas but not for an in vivo calibration procedure, of a peritoneally implanted glucose sensor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668080     DOI: 10.1007/bf00277254

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  The intravenous, intraperitoneal, and subcutaneous routes of insulin delivery in diabetic man.

Authors:  D S Schade; R P Eaton; N Friedman; W Spencer
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

2.  A new glucose electrode for tissue measurements.

Authors:  M Kessler; J Höper; H J Volkholz; D Sailer; L Demling
Journal:  Hepatogastroenterology       Date:  1984-12

3.  The kinetics of peritoneal insulin absorption.

Authors:  D S Schade; R P Eaton; T Davis; F Akiya; E Phinney; R Kubica; E A Vaughn; P W Day
Journal:  Metabolism       Date:  1981-02       Impact factor: 8.694

4.  Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane.

Authors:  G M O'Shea; M F Goosen; A M Sun
Journal:  Biochim Biophys Acta       Date:  1984-05-22

5.  Clinical experience in human diabetics with portable and implantable insulin minipumps.

Authors:  J Mirouze; J L Selam; A Slingeneyer; P A Chaptal; B Hedon; P Mares; M Franetzki; K Prestele; P Millet; J J Beraud
Journal:  Life Support Syst       Date:  1983 Jan-Mar

6.  Prolonged release of insulin by cholesterol-matrix implant.

Authors:  P Y Wang
Journal:  Diabetes       Date:  1987-09       Impact factor: 9.461

7.  Controlled release of insulin from polymer matrices. Control of diabetes in rats.

Authors:  L Brown; C Munoz; L Siemer; E Edelman; R Langer
Journal:  Diabetes       Date:  1986-06       Impact factor: 9.461

8.  Glucose concentration at possible sensor tissue implant sites.

Authors:  S K Wolfson; J F Tokarsky; S J Yao; M A Krupper
Journal:  Diabetes Care       Date:  1982 May-Jun       Impact factor: 19.112

9.  Glycosylated insulin complexed to Concanavalin A. Biochemical basis for a closed-loop insulin delivery system.

Authors:  M Brownlee; A Cerami
Journal:  Diabetes       Date:  1983-06       Impact factor: 9.461

10.  Use of a physiologic pharmacokinetic model of glucose homeostasis for assessment of performance requirements for improved insulin therapies.

Authors:  J T Sorensen; C K Colton; R S Hillman; J S Soeldner
Journal:  Diabetes Care       Date:  1982 May-Jun       Impact factor: 19.112

View more
  5 in total

1.  Glucose tolerance and plasma insulin response to intravenous glucose infusion and test meal in rats with microencapsulated islet allografts.

Authors:  W M Fritschy; J H Strubbe; G H Wolters; R van Schilfgaarde
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

2.  The role of dysregulated glucose metabolism in epithelial ovarian cancer.

Authors:  L D Kellenberger; J E Bruin; J Greenaway; N E Campbell; R A Moorehead; A C Holloway; J Petrik
Journal:  J Oncol       Date:  2010-02-17       Impact factor: 4.375

3.  Measurement and modeling of the transient difference between blood and subcutaneous glucose concentrations in the rat after injection of insulin.

Authors:  D W Schmidtke; A C Freeland; A Heller; R T Bonnecaze
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

4.  Glucose sensing in the peritoneal space offers faster kinetics than sensing in the subcutaneous space.

Authors:  Daniel R Burnett; Lauren M Huyett; Howard C Zisser; Francis J Doyle; Brett D Mensh
Journal:  Diabetes       Date:  2014-03-12       Impact factor: 9.461

5.  Effect of sensor location on continuous intraperitoneal glucose sensing in an animal model.

Authors:  Marte Kierulf Åm; Konstanze Kölle; Anders Lyngvi Fougner; Ilze Dirnena-Fusini; Patrick Christian Bösch; Reinold Ellingsen; Dag Roar Hjelme; Øyvind Stavdahl; Sven Magnus Carlsen; Sverre Christian Christiansen
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.